Founded in 2019, Exo, a developer of highly portable ultrasound technology, has made waves across the healthcare technology ecosystem. Exo, established in 2015. The innovative imaging technology company designs revolutionary handheld medical imaging devices incorporating cutting-edge artificial intelligence, advanced medical imaging, and silicon technology. As such, the company has managed to raise north of $320 million in funding to date. This includes a whopping $220 million from its 2021 Series C round.
Exo’s ultrasound machines are transforming how those examinations are performed. They empower healthcare workers of almost any level to conduct ultrasound assessments, including novel lung ultrasonography and echocardiograms, with unparalleled simplicity. The breakthrough technology means practitioners can plug the lightweight imaging device directly into a smartphone making it quick and easy to scan patients. With it, medical examiners can document, create and share comprehensive exam reports with a single mobile app. This innovation provides a significant workflow efficiency improvement in clinical settings.
The company’s big name investor register is further testament to its market potential and credibility. Since then Exo has drawn investment from a string of high-profile firms. Other notable backers are RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners. This eclectic support further highlights the belief top players in the investment community, such as the Carlyle Group and Allen & Company, have in Exo’s vision and technology.
This boost comes on the heels of recent reports from industry insiders claiming that Samsung is looking to make a $100 million bet on Exo. There are few details known about the possible agreement so far. Despite that, this would be a game-changing investment for Exo, practically doubling Exo’s cash reserves and expanding its foothold within the lucrative medical imaging market.
With a dedication to bringing ultrasound devices to the commercial sector through innovative technology, Exo is primed for continued growth. Recent developments in medical imaging technology and the increasing need for compact, point-of-care diagnostic solutions are revolutionizing patient care. Exo is excited to be at the forefront of this evolution.
Leave a Reply